Clinical Trial CTSUBRES1007-M
Title
Phase III randomized trial of standard adjuvant endocrine therapy +/- chemo in patients with 1-3 positive nodes, hormone receptor positive and Her2 negative breast cancer with recurrence score (RS) of 25 or less
Principal Investigator(s)
John Murray
Details
- Protocol No. CTSUBRES1007-M
- Open Date: 05/25/2011
- Staging: Phase III
- Age Group: Adults
- Scope: National
- Objective:
- Disease Sites: Breast
- Therapies: None Specified
- Drugs: None Specified
- Participating Institutions: Advantage Clinical Research; Meharry Medical College
- Secondary Protocol No: S1007
Description
None Provided.
Eligibility
Not provided. Please call for more information.
Learn More
- Call toll-free number: 1-800-811-8480
- Use our Online self–referral form
- Print this page for your doctor
You do not have JavaScript enabled. This site works better with JavaScript turned on.
